HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stratton, J. R. Articles by Kohler, T. R. Search for Related Content PubMed PubMed Citation Articles by Stratton, J. R. Articles by Kohler, T. R.

Imaging Arterial Thrombosis: Comparison of Technetium-99m-Labeled Monoclonal Antifibrin Antibodies and Indium-111-Platelets

Division of Cardiology, Department of Medicine and the Department of Surgery, Seattle VA Medical Center and University of Washington, Seattle, Washington

Correspondence: For correspondence or reprints contact: John R. Stratton, MD, Cardiology (111 C), Seattle VA Medical Center, 1660 South Columbian Way, Seattle, WA 98108.

ABSTRACT

Imaging with the ^99mTc-T2G1s monoclonal antifibrin antibody fragment (Fab') has demonstrated promise in the noninvasive detection of venous thrombi in humans. The purpose of this study was to determine whether chronic arterial thrombi can also be detected by antifibrin antibody imaging. Methods: Eighteen subjects with chronic arterial thrombi were studied with planar and tomographic imaging at 0 to 24 hr postinjection of ^99mTc-labeled T2G1s monoclonal antifibrin antibody fragment. Imaging with ¹¹In-labeled platelets was also performed. Images were visually graded by two observers as 0, 1, 2 or 3 (no, faint, moderate or marked) uptake, and quantitative analysis of tomographic images was done in 13 subjects. Results: On visual analysis of planar images, 44% (8 of 18) of antifibrin patient studies were 1.0 or more and 66% (10 of 18) were judged negative compared with 94% (15 of 16) of platelet patient studies judged 1.0 or more and 6% (1 of 16) judged as negative (p < 0.01). Visual analysis of tomographic images was similar, with 61% (11 of 18) of antifibrin studies graded 1.0 or more compared with 100% (17 of 17) of platelet studies (p < 0.01). The tomographic target-to-background ratio was higher with platelets than with antifibrin antibody (2.5 ± 1.4 versus 1.8 ± 1.0, p < 0.05). Conclusion: In the large-vessel chronic arterial thrombi studied, the results of ^99mTc-labeled monoclonal T2G1s antifibrin Fab' imaging were positive in only one-half of the patients studied, significantly less than the findings with platelet imaging, which were positive in all subjects. The higher rate of positive images with labeled platelets than with labeled antifibrin antibodies may be largely due to thrombus age, with continued platelet deposition but little active fibrin deposition.

Key Words: thrombosis imaging • platelet imaging • monoclonal antibodies

This article has been cited by other articles:

				J. R. Davies, J. H. Rudd, and P. L. Weissberg Molecular and Metabolic Imaging of Atherosclerosis J. Nucl. Med., November 1, 2004; 45(11): 1898 - 1907. [Abstract] [Full Text] [PDF]

				M. Ciavolella, R. Tavolaro, M. Di Loreto, F. La Torre, A. Nicolai, O. Schillaci, M. Ierardi, F. Scopinaro, and M. Ciavolella Immunoscintigraphy of Venous Thrombi: Clinical Effectiveness of a New Antifibrin D-Dimer Monoclonal Antibody Angiology, February 1, 1999; 50(2): 103 - 109. [Abstract] [PDF]